Acquisition Adds New Products and Significant Technology Capabilities BURLINGTON, Mass. and CAMBRIDGE, Mass., Jan. 7, 2014 /PRNewswire/ — Piramal Enterprises’ Information Management Subsidiary, Decision Resources Group, one of the world’s leading research and advisory firms focusing on high-value healthcare insights and analytics, announced today that it acquired Relay Technology Management, a data analytics company focused […]
Relay Technology Management Inc. and MedPanel, LLC are pleased to announce they have entered into a working partnership to offer a differentiated set of consultative services to biopharma business executives. Under this collaboration, MedPanel’s industry-leading primary research platform, Insights, which provides insight from clinicians and other healthcare decision makers, and Relay’s Innovation Engine-powered solutions will […]
Relay Technology Management Publishes Macrocyclic Peptide Interactive Dashboard in Nature SciBx Collection
Relay Technology Management Inc. is pleased to announce that its real-time, interactive macrocyclic peptide dashboard has been featured in a SciBX; Science-Business eXchange collection. The collection on Macrocycles and Constrained Peptides features prominent scientific papers, review articles, and analysis pieces, with a focus on the potential these molecules have to open up new space for […]
Nature Publishing Group Publishes Open-Access Article Containing Relay’s Next Generation Epigenetics Drug Target Dashboard
Nature Publishing Group Releases Open-Access Article Containing Next Generation Epigenetics Drug Target Dashboard Powered by Relay Technology Management First of six open-access articles featuring dashboards from Nature’s strategic partner published today in Nature Reviews Drug Delivery CAMBRIDGE, MA – Relay Technology Management Inc. is pleased to announce that a series of six articles featuring Relay […]
By: David Worlock “It was inevitable that some readers of my piece on Gold OA earlier this week would come back and say that I have grown too fond of defining what won’t work and should become more proactive about stating the new directions. Fair cop. Here then are two “assertions” about that future for […]
By: Ryan McBride ‘Data rules in biotech, and such has been the case for decades. Yet a series of breakthroughs in genomics and computing over the past several years have compounded the amounts of data available to scientists by many factors; now the biotech industry faces fantastic opportunities and challenges from Big Data.’ (Read full article).
By: Jeff Kelly, Wikibon Analyst “To derive business value from Big Data Analytics, practitioners must incorporate unstructured data & content into the equation. This was the premise put forth by Brigham Hyde of Relay Technology Management to the Wikibon community at the July 10th, 2012 Peer Incite.” (Read full article.)
Shelly Kraft of Stock News Now interviews Dave Greenwald, Ph.D. at Bio International Boston. Shelly and Dave discuss Relay’s 2012 developments, like the launch of BD Live!, the Relay Relative Value Index (RVI) and the Relay Innovation Engine (RIE)
Case Study on Relay Technology Management Develops Biopharma Industry’s First Unified Solution for Real-time Business Intelligence and Data Visualization
Relay Technology Management Develops Biopharma Industry’s First Unified Solution for Real-time Business Intelligence and Data Visualization From: TIBCO Spotfire “The life sciences industry has no shortage of information technology companies that provide business development executives with piles of raw data on everything from targets and clinical trials to researchers and institutions. The data sources – […]
By: Maria Deutscher “Relay dubs itself as a life sciences big data company. It applies insight from unstructured and structured data sets to the pharmaceutical process, and offers value in the laboratory rather than directly from the business angle.” Read full article.